Related Experiment Video
Updated: Aug 4, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Case report: Albendazole associated psychosis
This case report details the first instance of psychosis linked to albendazole monotherapy. Patient recovery occurred after discontinuing albendazole and starting aripiprazole, suggesting a causal relationship.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- The link between albendazole monotherapy and psychosis is not well-documented in existing medical literature.
- Albendazole is a widely used antiparasitic medication.
Observation:
- A patient developed acute psychosis during albendazole treatment.
- Psychosis symptoms resolved after albendazole was stopped and aripiprazole was initiated.
Findings:
- The temporal association and available data strongly suggest albendazole induced the psychotic reaction.
- This adverse event highlights a potential neurotoxicity of albendazole.
Implications:
- Healthcare providers should consider the risk of psychosis when prescribing albendazole.
- Awareness of this rare but severe adverse effect is crucial for patient safety and management.
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Fungal Phylum Microsporidia
Rocky Mountain Spotted Fever
Amebiasis
Anthelminthic Agents